May 04, 2007 02:20 ET

DSM - Repurchase of shares


Royal DSM N.V. has repurchased 504,980 of its own shares in the period from 27 April 2007 up to and including 2 May 2007 at an average price of EUR 34.77. This is in accordance with the second phase of the share buyback program announced on 27 April 2007. The consideration of this repurchase was EUR 17.6 million.


DSM is active worldwide in nutritional and pharma ingredients, performance materials and industrial chemicals. The company develops, produces and sells innovative products and services that help improve the quality of life. DSM's products are used in a wide range of end-markets and applications, such as human and animal nutrition and health, personal care, pharmaceuticals, automotive and transport, coatings and paint, housing and electrics & electronics (E&E). DSM's strategy, named Vision 2010 - Building on Strengths, focuses on accelerating profitable and innovative growth of the company's specialties portfolio. The key drivers of this strategy are market-driven growth and innovation plus an increased presence in emerging economies. The group has annual sales of over EUR 8 billion and employs some 22,000 people worldwide. DSM ranks among the global leaders in many of its fields. The company is headquartered in the Netherlands, with locations in Europe, Asia, Africa, Australia and the Americas. More information about DSM can be found at

For more information:
DSM Corporate Communications    DSM Investor Relations
Elvira Luykx                    Dries Ausems
tel. +31 (0) 45 5782035         tel. +31 (0) 45 5782864
fax  +31 (0) 45 5740680         fax  +31 (0) 45 5782595
e-mail  e-mail

Copyright © Hugin ASA 2007. All rights reserved.

Contact Information